Biotage AB (Nasdaq OMX Stockholm: BIOT.ST)

https://www.biotage.com

Twitter: @Biotage

Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical companies and food manufacturers, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 405 employees and had sales of 911 MSEK in 2018. Biotage is listed on NASDAQ Stockholm. *

	Start	2003-12-01 renamed
	Group	Biotage (Group)
	Predecessor	Pyrosequencing AB
	Industry	BIOTECH
	Industry 2	laboratory equipment and instruments
	Person	Blomquist, Tomas (Biotage 201911– CEO before Abbott EMEA + Alere + Analyticon + JnJ + Roche)
	Person 2	Eklund, Thomas (Investor Growth Capital + Alfred Berg ABN AMRO Capital Investment + Handelsbanken)

	Region	Uppsala
	Country	Sweden
	Street	76 Kungsgatan
	City	753 18 Uppsala
	Tel	+46-18-565900
		Address record changed: 2020-12-02

Basic data	Employees	D: 101 to 500 (2014-12-31)
	Currency	SEK
	Annual sales	911,000,000 (sales, consolidated (2018) 2018-12-31)

		* Document for »About Section«: Biotage AB. (6/4/19). "Press Release: Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications". Uppsala.

		Record changed: 2023-07-10